DrugDashboards

Cold Head Congestion Severe

ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE · ACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 · Tablet, Coated · Oral · AmeriSource Bergen

NDC 46122-0415-62 · 2 BLISTER PACK in 1 CARTON / 12 TABLET, COATED in 1 BLISTER PACK · OTC MONOGRAPH DRUG · View full market →

The short version

32 companies supply this market — deep enough that no single failure threatens the supply. The price is down 10% over the past year, to $0.1047 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1$0.15Jan 2023Sep 2026$0.1047
45 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$3.14
#90 count
$9.42

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2024)

$193
18 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for acetaminophen, guaifenesin, and phenylephrine hydrochloride (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
M012
TE code
—
Approval date
—
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE (Tablet, Coated)

LabelerStrengthFirst seenLast seen
AmeriSource BergenACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Chain Drug Marketing AssociationACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Chain Drug Marketing Association, Inc.ACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Discount Drug MartACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Hyvee IncACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Marc Glassman, Inc.ACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
MeijerACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Reckitt Benckiser LLCACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Amerisource BergenACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Cardinal HealthACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Chain Drug Marketing Association IncACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
GoodsenseACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Harris TeeterACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Kenvue Brands LLCACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Marc Glassman, Inc.ACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Morning Star OTCACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Navajo Manufacturing Company Inc.ACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
RB Health (US) LLCACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Retail Business Services , LLC.ACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Retail Business Services , Llc.ACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Select Consumer Group LLCACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Strategic Sourcing Services LlcACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
TopCareGUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1; ACETAMINOPHEN 325 mg/1Aug 26, 2026Sep 2, 2026
TopcareACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
TopCo Associates LLCACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
United Natural Foods, Inc. dba UNFIACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Winco Foods, LLCACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
GoodSenseACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Aug 31, 2026
Harris TeeterACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Aug 31, 2026
HebACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Aug 31, 2026
Lil Drug Store Products, IncACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Aug 31, 2026
Valu Merchandisers CompanyACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Aug 31, 2026
TopCareGUAIFENESIN 325 mg/1; PHENYLEPHRINE HYDROCHLORIDE 200 mg/1; ACETAMINOPHEN 5 mg/1Jul 22, 2026Aug 19, 2026
Chain Drug ConsortiumACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Jul 31, 2026
Cvs PharmacyACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Jul 29, 2026
Meijer Distribution IncACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Jul 29, 2026
TopCareACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Cold Head Congestion Severe — NDC 46122-0415-62," retrieved September 3, 2026, https://drugdashboards.com/drug/46122041562.

Free to cite with attribution — see how the data is put together.